Purpose Giant prolactinomas, which have extremely large sizes and high prolactin (PRL)
values, are rarely seen. Although medical therapy is effective, surgical treatment is more …

Objective: To describe outcomes of patients with giant prolactinoma (≥ 4 cm) and identify
predictors of therapeutic response. Methods: In this retrospective study, complete …

Purpose Giant prolactinomas are a rare entity, representing approximately 5% of all
prolactinomas. A systematic review of 196 adult cases was performed. A comparison of the …

Background Giant prolactinomas are an unusual subset of macroprolactinomas and are
more commonly found in men. The goal of this review is to propose a giant prolactinoma …

Giant prolactinomas are rare tumors characterized by their large size, compressive
symptoms, and extremely high prolactin secretion. The aim of this study is to describe our …

Background The management of giant prolactinomas remains a major challenge, despite
dopamine agonists being the first line of treatment, owing to its efficacy to normalize …

Purpose To describe the clinical presentation and treatment outcomes in a nationwide
cohort of patients with giant prolactinomas. Methods Register-based study of patients with …

Giant prolactinomas (gPRLomas) are rare tumors of the lactotroph defined by an unusually
large size (> 4 cm) and serum PRL levels> 1000 ng/mL. The purpose of this study is to …

Background: Management of giant prolactinomas presents a different challenge than the
management of traditional prolactinomas. Objective: The aim of this study was to report the …

Introduction. Giant prolactinoma (GP) is a rare pituitary lactotropic cell tumor larger than 4 cm
in its widest dimension, and is less likely than a smaller prolactinoma to achieve prolactin …